Inotiv, Inc. (NOTV)
USD 1.55
(3.33%)
USD 1.55
(3.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 56.1 Million USD | -21.47% |
| 2022 | 71.44 Million USD | 11767.28% |
| 2021 | 602 Thousand USD | -14.0% |
| 2020 | 700 Thousand USD | -36.07% |
| 2019 | 1.09 Million USD | -7.36% |
| 2018 | 1.18 Million USD | 29.46% |
| 2017 | 913 Thousand USD | -37.16% |
| 2016 | 1.45 Million USD | -0.89% |
| 2015 | 1.46 Million USD | -6.27% |
| 2014 | 1.56 Million USD | 13.42% |
| 2013 | 1.37 Million USD | -16.73% |
| 2012 | 1.65 Million USD | 1.22% |
| 2011 | 1.63 Million USD | -2.21% |
| 2010 | 1.67 Million USD | -9.42% |
| 2009 | 1.84 Million USD | -15.43% |
| 2008 | 2.18 Million USD | 10.47% |
| 2007 | 1.97 Million USD | 4.76% |
| 2006 | 1.88 Million USD | -7.56% |
| 2005 | 2.04 Million USD | 30.02% |
| 2004 | 1.57 Million USD | -23.61% |
| 2003 | 2.05 Million USD | -21.68% |
| 2002 | 2.62 Million USD | 9.74% |
| 2001 | 2.39 Million USD | 7.0% |
| 2000 | 2.23 Million USD | 24.15% |
| 1999 | 1.8 Million USD | -5.26% |
| 1998 | 1.9 Million USD | 0.0% |
| 1997 | 1.9 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 64.41 Million USD | 14.81% |
| 2024 Q3 | 58.63 Million USD | -42.04% |
| 2024 Q2 | 66.73 Million USD | 3.61% |
| 2023 FY | 56.1 Million USD | -21.47% |
| 2023 Q4 | 56.1 Million USD | 4.05% |
| 2023 Q3 | 53.92 Million USD | -16.12% |
| 2023 Q2 | 64.28 Million USD | -15.01% |
| 2023 Q1 | 75.63 Million USD | 5.88% |
| 2022 Q1 | 36.06 Million USD | 5891.03% |
| 2022 Q3 | 66.4 Million USD | 16.95% |
| 2022 Q4 | 71.44 Million USD | 7.59% |
| 2022 FY | 71.44 Million USD | 11767.28% |
| 2022 Q2 | 56.77 Million USD | 57.42% |
| 2021 Q4 | 602 Thousand USD | -38.38% |
| 2021 FY | 602 Thousand USD | -14.0% |
| 2021 Q3 | 977 Thousand USD | 12.04% |
| 2021 Q2 | 872 Thousand USD | -0.46% |
| 2021 Q1 | 876 Thousand USD | 25.14% |
| 2020 Q3 | 1.49 Million USD | 23.75% |
| 2020 Q1 | 1.03 Million USD | -5.57% |
| 2020 Q2 | 1.2 Million USD | 16.44% |
| 2020 Q4 | 700 Thousand USD | -53.02% |
| 2020 FY | 700 Thousand USD | -36.07% |
| 2019 FY | 1.09 Million USD | -7.36% |
| 2019 Q4 | 1.09 Million USD | -2.14% |
| 2019 Q3 | 1.11 Million USD | 1.45% |
| 2019 Q2 | 1.1 Million USD | -5.81% |
| 2019 Q1 | 1.17 Million USD | -0.93% |
| 2018 Q4 | 1.18 Million USD | 22.61% |
| 2018 FY | 1.18 Million USD | 29.46% |
| 2018 Q3 | 964 Thousand USD | -3.6% |
| 2018 Q2 | 1 Million USD | 7.41% |
| 2018 Q1 | 931 Thousand USD | 1.97% |
| 2017 Q2 | 1.11 Million USD | -18.14% |
| 2017 FY | 913 Thousand USD | -37.16% |
| 2017 Q1 | 1.36 Million USD | -5.92% |
| 2017 Q3 | 1.06 Million USD | -4.92% |
| 2017 Q4 | 913 Thousand USD | -14.19% |
| 2016 Q2 | 1.41 Million USD | -1.26% |
| 2016 Q1 | 1.43 Million USD | -2.18% |
| 2016 Q4 | 1.45 Million USD | -1.56% |
| 2016 FY | 1.45 Million USD | -0.89% |
| 2016 Q3 | 1.47 Million USD | 4.24% |
| 2015 Q2 | 1.67 Million USD | 0.6% |
| 2015 Q4 | 1.46 Million USD | -6.09% |
| 2015 Q1 | 1.66 Million USD | 6.27% |
| 2015 Q3 | 1.56 Million USD | -6.64% |
| 2015 FY | 1.46 Million USD | -6.27% |
| 2014 Q2 | 1.5 Million USD | 3.86% |
| 2014 Q3 | 1.53 Million USD | 1.86% |
| 2014 Q4 | 1.56 Million USD | 1.89% |
| 2014 Q1 | 1.45 Million USD | 5.22% |
| 2014 FY | 1.56 Million USD | 13.42% |
| 2013 Q4 | 1.37 Million USD | -6.76% |
| 2013 FY | 1.37 Million USD | -16.73% |
| 2013 Q3 | 1.47 Million USD | -10.53% |
| 2013 Q2 | 1.65 Million USD | -2.94% |
| 2013 Q1 | 1.7 Million USD | 2.84% |
| 2012 Q2 | 1.85 Million USD | -0.43% |
| 2012 Q4 | 1.65 Million USD | -5.1% |
| 2012 Q3 | 1.74 Million USD | -5.88% |
| 2012 FY | 1.65 Million USD | 1.22% |
| 2012 Q1 | 1.86 Million USD | 13.81% |
| 2011 Q4 | 1.63 Million USD | -0.67% |
| 2011 Q1 | 1.61 Million USD | -3.29% |
| 2011 Q2 | 1.56 Million USD | -3.21% |
| 2011 Q3 | 1.64 Million USD | 5.17% |
| 2011 FY | 1.63 Million USD | -2.21% |
| 2010 Q3 | 1.71 Million USD | -10.36% |
| 2010 FY | 1.67 Million USD | -9.42% |
| 2010 Q2 | 1.91 Million USD | -4.69% |
| 2010 Q1 | 2 Million USD | 8.61% |
| 2010 Q4 | 1.67 Million USD | -2.39% |
| 2009 Q4 | 1.84 Million USD | -3.45% |
| 2009 Q2 | 2.02 Million USD | -7.65% |
| 2009 FY | 1.84 Million USD | -15.43% |
| 2009 Q1 | 2.19 Million USD | 0.55% |
| 2009 Q3 | 1.91 Million USD | -5.67% |
| 2008 Q2 | 2.13 Million USD | 6.23% |
| 2008 FY | 2.18 Million USD | 10.47% |
| 2008 Q1 | 2 Million USD | 1.42% |
| 2008 Q3 | 2.17 Million USD | 2.07% |
| 2008 Q4 | 2.18 Million USD | 0.46% |
| 2007 Q2 | 1.97 Million USD | -10.76% |
| 2007 Q4 | 1.97 Million USD | 9.47% |
| 2007 Q3 | 1.8 Million USD | -8.46% |
| 2007 FY | 1.97 Million USD | 4.76% |
| 2007 Q1 | 2.21 Million USD | 17.16% |
| 2006 Q3 | 1.88 Million USD | -14.41% |
| 2006 Q4 | 1.88 Million USD | -0.1% |
| 2006 Q1 | 2.26 Million USD | 10.71% |
| 2006 Q2 | 2.2 Million USD | -2.35% |
| 2006 FY | 1.88 Million USD | -7.56% |
| 2005 Q4 | 2.04 Million USD | -8.99% |
| 2005 Q2 | 2.25 Million USD | 31.34% |
| 2005 Q1 | 1.72 Million USD | 9.55% |
| 2005 Q3 | 2.24 Million USD | -0.71% |
| 2005 FY | 2.04 Million USD | 30.02% |
| 2004 Q3 | 1.83 Million USD | -4.78% |
| 2004 FY | 1.57 Million USD | -23.61% |
| 2004 Q4 | 1.57 Million USD | -14.35% |
| 2004 Q1 | 2.2 Million USD | 7.19% |
| 2004 Q2 | 1.92 Million USD | -12.62% |
| 2003 Q1 | 2.58 Million USD | -1.64% |
| 2003 Q4 | 2.05 Million USD | -15.01% |
| 2003 FY | 2.05 Million USD | -21.68% |
| 2003 Q3 | 2.41 Million USD | 0.12% |
| 2003 Q2 | 2.41 Million USD | -6.43% |
| 2002 Q1 | 2.96 Million USD | 23.79% |
| 2002 Q3 | 2.71 Million USD | 0.18% |
| 2002 Q4 | 2.62 Million USD | -3.24% |
| 2002 FY | 2.62 Million USD | 9.74% |
| 2002 Q2 | 2.7 Million USD | -8.55% |
| 2001 Q1 | 2.33 Million USD | 4.58% |
| 2001 Q4 | 2.39 Million USD | -1.52% |
| 2001 FY | 2.39 Million USD | 7.0% |
| 2001 Q2 | 2.29 Million USD | -1.84% |
| 2001 Q3 | 2.42 Million USD | 5.84% |
| 2000 Q1 | 1.9 Million USD | 5.56% |
| 2000 Q2 | 2.19 Million USD | 15.58% |
| 2000 Q3 | 2.07 Million USD | -5.42% |
| 2000 Q4 | 2.23 Million USD | 7.59% |
| 2000 FY | 2.23 Million USD | 24.15% |
| 1999 Q3 | 2 Million USD | 5.26% |
| 1999 Q4 | 1.8 Million USD | -10.0% |
| 1999 FY | 1.8 Million USD | -5.26% |
| 1999 Q1 | 1.9 Million USD | 0.0% |
| 1999 Q2 | 1.9 Million USD | 0.0% |
| 1998 Q3 | 2.1 Million USD | 0.0% |
| 1998 FY | 1.9 Million USD | 0.0% |
| 1998 Q2 | 2.1 Million USD | 10.53% |
| 1998 Q1 | 1.9 Million USD | -0.52% |
| 1998 Q4 | 1.9 Million USD | -9.52% |
| 1997 FY | 1.9 Million USD | 0.0% |
| 1997 Q4 | 1.91 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aspira Women's Health Inc. | 227 Thousand USD | -24614.537% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -303416.555% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -7115.348% |
| Standard BioTools Inc. | 20.53 Million USD | -173.228% |
| Prenetics Global Limited | 3.12 Million USD | -1694.244% |
| Neuronetics, Inc. | 8.09 Million USD | -593.216% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -1540.409% |
| Castle Biosciences, Inc. | 7.94 Million USD | -606.396% |
| Psychemedics Corporation | 1.00 USD | -5610199900.0% |
| RadNet, Inc. | 1.00 USD | -5610199900.0% |
| Exact Sciences Corporation | 127.47 Million USD | 55.99% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 85.247% |
| iSpecimen Inc. | - USD | -Infinity% |
| OpGen, Inc. | 1.00 USD | -5610199900.0% |
| Exagen Inc. | 2.87 Million USD | -1854.093% |
| Bionano Genomics, Inc. | 22.89 Million USD | -145.062% |
| CareDx, Inc | 19.47 Million USD | -188.131% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | -74.974% |
| Guardant Health, Inc. | 61.94 Million USD | 9.437% |
| Biodesix, Inc. | 1.4 Million USD | -3907.286% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -4830.874% |
| Precipio, Inc. | 384 Thousand USD | -14509.896% |
| Natera, Inc. | 40.75 Million USD | -37.643% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -862.794% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| 23andMe Holding Co. | 12.46 Million USD | -350.076% |
| OPKO Health, Inc. | 65.69 Million USD | 14.605% |
| Personalis, Inc. | 5.66 Million USD | -891.026% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -16899.215% |
| T2 Biosystems, Inc. | 4.81 Million USD | -1064.183% |
| Neogen Corporation | 189.26 Million USD | 70.358% |
| Myriad Genetics, Inc. | 20.1 Million USD | -179.114% |
| ICON Public Limited Company | 1.00 USD | -5610199900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | -132.249% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -1540.409% |
| MDxHealth SA | 2.77 Million USD | -1918.784% |
| Prenetics Global Limited | 3.12 Million USD | -1694.244% |
| Illumina, Inc. | 587 Million USD | 90.443% |
| DarioHealth Corp. | 5.06 Million USD | -1008.297% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -2038.959% |
| Medpace Holdings, Inc. | 1.00 USD | -5610199900.0% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -9042.524% |
| Trinity Biotech plc | 19.93 Million USD | -181.453% |
| Sotera Health Company | 51.98 Million USD | -7.92% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -303416.555% |